![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 22607-22610, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Integrin adhesion receptors link the
extracellular matrix (ECM)1
to the actin cytoskeleton and transmit biochemical signals and mechanical force across the plasma membrane. This enables cells to
generate traction during migration and exert tension during matrix
remodeling (1). Cytoskeletal linkages also enable integrins to mediate
cell adhesion and regulate cell shape and gene expression (1). Here we
will summarize the evidence for direct interactions between integrin
cytoplasmic tails and specific actin-binding proteins and discuss how
these interactions influence cell adhesion, cell spreading, and migration.
Integrin In addition to mediating integrin linkages with the actin cytoskeleton,
Mutational analysis of the 47-amino acid Integrins are linked to actin filaments by specific actin-binding
proteins, and there is now an emerging consensus concerning which
proteins are involved (Fig. 1).
Talin-mediated Linkages--
Talin is composed of two ~270-kDa
subunits arranged as an anti-parallel homodimer (8), and it
co-localizes with integrins at certain sites of cell-substratum
contact. Talin is a major structural component of FA along with actin
and vinculin. It consists of an N-terminal ~50-kDa globular head
domain, which includes an ~200-amino acid region with homology to the
ezrin, radixin, and moesin (ERM) family of proteins, and an ~220-kDa,
C-terminal rod domain containing a conserved ILWEQ actin-binding domain
(8, 13). Talin contains binding sites for actin, vinculin, focal adhesion kinase, phospholipids, and the transmembrane protein laylin
(8, 14). Talin was the first actin-binding protein shown to directly
bind integrins and was proposed to mediate the link to the actin
cytoskeleton (2). Talin binds to
The significance of talin for integrin function has been underscored by
studies of talin-null ES cells, which exhibit extensive membrane
blebbing, defects in cell adhesion and spreading, and a failure to
assemble FA or stress fibers (21). These results suggest that talin is
required for the integrin-cytoskeleton associations needed for FA and
stress fiber formation. However, undifferentiated talin-null ES cells
also express reduced levels of
Integrin-binding sites have been localized to both the talin-head and
rod domains (17, 18), suggesting that binding of two or more integrin
However, other regions of the Filamin-mediated Linkages--
Three distinct filamin genes have
been reported, and alternative splicing allows for additional isoforms
(25). Filamins are actin filament cross-linking proteins composed of
two parallel 280-kDa subunits. Each subunit contains an N-terminal
actin-binding domain composed of two calponin homology domains,
followed by 23 repeating domains (8, 13). Depending on the
filamin:F-actin ratio, filamin reinforces loose microfilament nets such
as those found in the cell cortex (Fig. 1) or tightly packed bundles as found in stress fibers (8). Filamin also binds to the cytoplasmic domains of transmembrane proteins (e.g. GP Ib
Other Integrin-binding Cytoskeletal Proteins--
Recent reports
suggest that additional proteins may serve as direct links between
integrin tails and the cytoskeleton. In platelets, the two tyrosines in
the Vinculin-mediated Interactions--
Vinculin, an ~120-kDa
molecule, is one of the most abundant FA proteins and interacts with
F-actin, talin, Integrins are subject to rapid regulation of their ligand binding
activity by intracellular signals, and this has been termed inside-out
signaling or integrin activation (38). Inside-out signaling may act by
1) inducing conformational changes in and altering the affinity of
integrin heterodimers and 2) clustering heterodimers into multimers.
These forms of modulation are not mutually exclusive, and they may
operate in a complementary manner to control both ligand binding and
postligand binding events (39).
Inside-out signals to integrins originate from diverse plasma membrane
receptors. As with signal propagation to other parts of the cell, these
excitatory receptors presumably regulate integrins by triggering
post-translational changes, such as phosphorylation/dephosphorylation, that affect the activity and/or subcellular localization of key enzymes
and substrates in integrin-regulatory pathways (40). Thus, cytoskeletal
proteins could modulate inside-out signaling by promoting the activity
of integrin-regulatory molecules and/or by controlling their proximity
to integrin cytoplasmic tails (38). Alternatively, or in addition,
certain cytoskeletal proteins might be able to modulate the integrin
activation state directly as the result of regulated changes in
integrin-cytoskeleton linkages. Furthermore, in cases where integrins
bind to counter-receptors on other cells instead of ECM, integrin
avidity may be influenced by cytoskeleton-driven alignment of the
membranes on the opposing cells (41).
As a possible example of regulation of integrin function by
cytoskeletal linkages, Regulated interactions between cytoskeletal proteins and integrin
cytoplasmic tails might also explain why
Cytoskeletal linkages may also be involved in the activation of
Rho family GTPases play a prominent role in actin polymerization and
reorganization during cell migration (9), and it is logical to consider
whether they are directly involved in promoting integrin activation. In
fibroblasts, activation of Cdc42 and Rac is associated with the
formation of focal complexes (9), but their effects on ligand binding
to integrins has not been studied. Inhibition of Rho with C3 exoenzyme
decreases The studies pointing to a role for actin and actin-binding
proteins in regulating integrin function have coincided with
remarkable recent advances in understanding the regulation of actin
filament assembly. Integrins may provide the appropriate subcellular
locale for actin filament assembly and organization in adherent and
migratory cells by virtue of integrin-cytoskeleton linkages and
integrin-triggered outside-in signals. In this context, several
proteins implicated in the regulation of actin assembly are either
components of FA or interact with cytoskeletal proteins that are linked
to integrin The Mena/VASP Family--
Members of this protein family, which
include VASP, the Drosophila protein Enabled (Ena), its
mammalian orthologue Mena, and Evl (Ena-VASP-like), contain conserved
N- and C-terminal domains (EVH1 and EVH2) separated by a proline-rich
domain that binds profilin and SH3 domains (49, 50) (Fig. 2). The VASP
EVH2 domain mediates tetramerization of the molecule, F-actin binding, and bundle formation (51). The EVH1 domain mediates targeting to FA by
binding to proline-rich motifs in zyxin and vinculin (Fig. 2) and binds
to the ActA movement protein of the intracellular bacteria Listeria
monocytogenes (49, 50). Mena/VASP proteins are localized to sites of
actin assembly, such as FA and membrane ruffles, and are concentrated
at the tips of rapidly moving lamellipodia and at the focal contacts at
their base (52). This localization of VASP is consistent with its
proposed role in linking membrane proteins, which presumably include
integrins, to polymerizing actin.
VASP is also a substrate for cyclic AMP-dependent protein
kinase A and cyclic GMP-dependent protein kinase G. In
platelets, cyclic AMP and cyclic GMP are potent inhibitors of
agonist-induced activation of
Investigation of ActA has provided insight into eukaryotic mechanisms
for regulating actin filament assembly (54). This has led to a model in
which Mena/VASP proteins are targeted to FA by binding to zyxin or
vinculin, which in turn bind
In summary, Mena/VASP proteins appear to contribute to F-actin binding
at FA but are not required for FA assembly or maintenance. Mena/VASP
proteins play important roles in regulating actin filament assembly,
particularly at the leading edge of migrating cells, and Mena/VASP
associations with integrins, although indirect, may target actin
polymerization to fresh sites of integrin-ECM contact.
Arp2/3 and WASP--
The studies on Listeria, which highlighted
the role of Mena/VASP, also revealed a requirement for the Arp2/3
complex for actin polymerization (54, 55). This complex consists of
seven proteins and co-localizes with Mena/VASP at the leading edges of
cells to promote the assembly of actin filament networks (55). Hence, recruitment of Arp2/3 to focal contacts containing integrin-associated Mena/VASP may contribute to actin assembly at sites of ECM contact (54). Machesky and Insall (55) describe a model for the activation of
Arp2/3 by extracellular signals, leading to regulated assembly of actin
filaments allowing production of force for cell motility and shape
changes. A critical question in this model is how the Arp2/3 complex
becomes localized at sites where actin polymerization is required, such
as lamellipodia.
Identification of members of the WASP (Wiskott-Aldrich syndrome
protein) family as Arp2/3-binding proteins (55) suggests a complex
multimolecular assembly, which may bring Arp2/3 into contact with
integrin-associated Mena/VASP (Fig. 2). Expression of WASP appears to
be limited to cells of hematopoietic lineage; however, two family
members, N-WASP and WAVE, have more widespread distributions (56). WASP
proteins are proline-rich scaffolding molecules and effectors of the
small GTPases, Cdc42 and Rac1 (56). WASP family members bind to actin,
either through a direct interaction or via profilin or Arp2/3, and so
may mediate some of the effects of Cdc42 or Rac on the cytoskeleton
(57). Overexpression of WASP or N-WASP in mammalian cells leads to
co-localization of F-actin with the overexpressed protein, and
WASP-coated beads accumulate F-actin and exhibit motility within cells
(56).
A model for Shigella motility suggests that co-localization
of vinculin, VASP, profilin, and N-WASP may drive actin polymerization (58). Although speculative, such co-localization may also occur in vivo via associations of Nck, PINCH, and ILK (integrin
linked kinase) with integrins (Fig. 2). ILK was identified as a binding protein of the integrin
In conclusion, integrins associate with the actin cytoskeleton through
a number of molecular linkages. In most cells, binding of the *
This minireview will be reprinted
in the 2000 Minireview Compendium, which
will be available in December, 2000. This is the second article of four in the
"Integrins Minireview Series." The authors acknowledge the support
of the National Institutes of Health.
¶
To whom correspondence should be addressed. Tel.:
858-784-7124; Fax: 858-784-7343; E-mail: ginsberg@scripps.edu.
Published, JBC Papers in Press, May 4, 2000, DOI 10.1074/jbc.R900037199
The abbreviations used are:
ECM, extracellular
matrix;
FA, focal adhesions;
ERM, ezrin, radixin, and moesin;
VASP, vasodilator-stimulated phosphoprotein;
WASP, Wiskott-Aldrich syndrome
protein;
ILK, integrin-linked kinase.
MINIREVIEW
Integrins and Actin Filaments: Reciprocal Regulation of Cell
Adhesion and Signaling*
,
§, and
¶
Department of Vascular Biology and
§ Molecular and Experimental Medicine, The Scripps Research
Institute, La Jolla, California 92037
![]()
INTRODUCTION
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES
![]()
Role of Integrin Cytoplasmic Tails in Integrin-Cytoskeleton
Linkages
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES
and
subunits are type I transmembrane proteins
expressed in surface membranes as heterodimers. Each consists of a
large extracellular domain, a single transmembrane segment, and a
relatively short cytoplasmic tail. The latter contains anywhere from 20 to 70 amino acid residues, with the notable exception of the much
larger
4 tail, which is linked primarily to intermediate filaments instead of actin filaments (2).
-Cytoplasmic tails are
necessary and sufficient to link integrins to the actin cytoskeleton (2). In contrast, there is less evidence to date that
tails are
directly linked to the cytoskeleton; indeed the removal of the
1,
4, or
IIb cytoplasmic
tail appears to increase
tail-mediated interactions with the
cytoskeleton (2). Direct binding of the signaling adapter protein
paxillin to
4 cytoplasmic tails has recently been
demonstrated, and this binding regulates
4
1-mediated cell spreading, migration,
and stress fiber formation (3). There is direct biochemical support for
the interaction of
and
tails with each other (4, 5) and for the
modulation of this interaction by the binding of ligands to the
extracellular domain (6). Consequently, regulated changes in the
interactions between the
and
tails may affect
integrin-cytoskeleton linkages.
cytoplasmic tails are important for adhesion, spreading, and
migration of cells on ECM, processes dependent on an intact actin
cytoskeleton. Integrins typically cluster within "matrix adhesions," sites of close apposition of the cell membrane to the
ECM. Matrix adhesions are extremely dynamic and heterogeneous structures with respect to size, composition, and orientation to actin
filaments (7, 9). The largest ones are usually referred to as focal
adhesions (FA), which are aligned at the ends of actin stress fibers
(2, 8, 9). As such, FA represent a morphologically prominent
association between integrins and the cytoskeleton, and investigation
of integrin targeting to FA has shed light on the mechanisms of
integrin-cytoskeleton association.
1 cytoplasmic
tail has identified three clusters of amino acids important for
integrin localization to FA, a membrane-proximal region and two
conserved NPXY (single-letter amino acid code) motifs (10).
Similar motifs in the
3 cytoplasmic tail are important
for localization of
3 integrins to FA (11). An
additional Thr-containing motif between the two NPXY sites
has also been implicated in
2 integrin-cytoskeleton linkages (12).
![]()
Specific Integrin-Cytoskeleton Linkages
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES

View larger version (23K):
[in a new window]
Fig. 1.
Models of the physical links between
integrins and F-actin. When known, the modular architecture of the
linking proteins is shown based on domain assignments by the SMART
program (13). The
integrin tail is depicted binding to ERM domains
within the talin head domain; however, integrin-binding sites have also
been identified in the rod domain. The spectrin repeats within the
-actinin rod domain mediate binding to the integrin
tail;
however, it is not known which of the three repeats contains the
binding site. Filamin binds integrins via C-terminal filamin repeats;
however, the exact binding site has not yet been determined.
1,
2, and
3 and more weakly to
7 integrin
cytoplasmic tails (15-18). Talin accumulation is an early step in FA
formation and requires integrins but not vinculin (19). Microinjection
of antibodies to talin or talin antisense RNA disrupts stress fibers
and inhibits adhesion, spreading, and migration of fibroblasts and HeLa
cells (8, 20).
1 integrin, vinculin, and
-actinin, which may contribute to the phenotype. Following
differentiation of talin-null ES cells, only two morphologically distinct cell types emerged, and no organized tissues were formed (21).
The differentiated cells expressed normal levels of
1 integrin and vinculin and were capable of spreading and forming actin
filaments and FA-like structures, indicating that in a subset of
differentiated cell types, intact talin is dispensable for maintenance
of
1 integrin expression and FA assembly.
tails to the talin dimer may facilitate integrin clustering (Fig.
1). Binding of both the head and rod domains are inhibited by Tyr to
Ala mutations in the membrane-proximal NPXY motif of
1 and
3 integrins (15, 17, 22),
consistent with the failure of integrins expressing this mutation to
localize to FA (10, 11). In v-Src-transformed cells, which exhibit reduced cell adhesion and a disorganized cytoskeleton, the
NPXY motif in the
1 tail is phosphorylated on
tyrosine, and talin binding is inhibited (23). Furthermore, synthetic
peptides spanning the NPXY motif bind purified talin and
inhibit talin binding to
1 (22, 23). Thus, the
talin-binding site in the
1 tail includes this sequence.
tail are likely to contribute to the
interaction with talin because the NPXY motif is highly conserved between integrin
subunits, but talin displays
differential binding to various integrin
tails (15). Indeed,
deletion of the C-terminal 13 amino acids of the
1
cytoplasmic tail, which leaves the membrane-proximal NPXY
site intact, inhibits both talin binding in vitro and
co-localization of talin and actin with clustered
1
integrins in vivo (22, 24). In contrast, deletion of only the four most C-terminal amino acids from
1 has no
effect on talin binding or recruitment of talin and actin to sites of
clustered integrins (22, 24). Furthermore, a recent report concluded that talin could bind specifically to peptides corresponding to the
membrane-proximal sequence of the
3 tail (18). Thus,
further work is required to determine the precise mode of interaction between integrin
tails and talin.
) and to
intracellular signaling molecules (e.g. RalA) (25, 26).
Filamin localizes to the cortical actin cytoskeleton and along the
length of stress fibers but is also found in some FA (8).
1A,
2,
3,
7, and to a lesser extent
1D integrin
tails can bind filamin, and Tyr to Ala point mutations in the
membrane-proximal
1 NPXY motif inhibit
binding (15, 27). Both filamin and F-actin are recruited to
1-containing FA in response to mechanical stress, but
F-actin recruitment does not take place in melanoma cells lacking
filamin (28). The gene encoding human filamin-1 is located on the X
chromosome, and mutations of this gene are associated with
periventricular heterotopia, indicating a requirement for filamin-1 in
neuronal migration during brain development (26). Loss of filamin-1
expression in neuronal or melanocytic cells results in impaired
migration and altered morphology (26, 29). However, filamin-1 null
melanocytic cells also have reduced levels of many cell surface
receptors, including
integrins (30), which may account for some of
these phenotypes.
-Actinin-mediated Linkages--
-Actinin is another
homodimeric actin-binding protein localized to FA (8). Non-muscle
-actinin monomers are ~100-kDa rodlike proteins containing three
functional domains: an N-terminal actin-binding domain composed of two
calponin homology domains, a central region of four spectrin-like
repeats, and a C-terminal domain containing two EF hands. At least two
-actinin genes and alternative splicing allow for production of a
number of
-actinin isoforms. In addition to binding F-actin,
-actinin binds the FA proteins vinculin, zyxin, and
1,
2, and
3 integrins (2, 8) (Figs. 1 and 2).
-Actinin targets
to FA in microinjected cells and in a cell-free system, apparently by
interaction with
cytoplasmic tails (31, 32). The binding sites for
-actinin have been localized to the membrane-proximal half of the
1 or
2 integrin tail, and binding to
2 is negatively regulated by sequences in the C-terminal
region of the tail (16). The membrane-proximal location of the
-actinin-binding site within
tails is consistent with the
observation that antibody-mediated clustering of
1
integrins lacking the C-terminal 13 amino acids also induces clustering of
-actinin (24). However,
-actinin binding to clustered
integrins is not sufficient to recruit F-actin (24, 32). Overexpression of
-actinin in fibroblasts leads to more stable attachment sites whereas isolated integrin-binding fragments of
-actinin disrupt stress fibers, FA, and shear-induced mechanical signaling in
fibroblasts and osteoblasts (8, 31).

View larger version (20K):
[in a new window]
Fig. 2.
Models for integrin localization of actin
nucleation and polymerization. VASP, profilin, Arp2/3, and WASP
may regulate actin filament assembly at sites of integrin-ECM contact.
Nck-2-WASP interactions have not been demonstrated but are hypothesized
on the basis of Nck-1 binding to WASP.
3 cytoplasmic tail become phosphorylated during
agonist-induced cell aggregation (33). Synthetic peptides corresponding
to the tyrosine-phosphorylated
3 tail bind to the
actin-binding protein, myosin (34). This interaction may be
physiologically relevant because conversion of the two
3
tail tyrosines to phenylalanine is associated with a mild bleeding
phenotype in mice (33). Skelemin, a cytoskeletal M-band protein, can
bind
1 and
3 but not
2
tails expressed in vitro (35). Skelemin co-localizes with
stably expressed
IIb
3 under some
conditions, and microinjection of the integrin-binding domain of
skelemin causes myoblasts to round up (35). Whether these interactions
represent widespread or specialized cases of integrin-cytoskeleton
linkages remains to be determined.
-actinin, paxillin, and vasodilator-stimulated
phosphoprotein (VASP) (8, 36). Vinculin does not bind directly to
integrins but may be recruited by integrin-bound talin or
-actinin
(Fig. 1). However, although reduced levels of vinculin result in a
reduction in the mechanical stiffness of the integrin-cytoskeleton
linkage and increased cell motility, vinculin-null ES cells can
differentiate in vitro into a variety of cell types (37) and
can spread and form talin-rich FA and stress fibers (21). Thus, despite
ubiquitous expression, vinculin is not absolutely required for some
integrin-F-actin linkages and is likely to function as a molecular
bridge to stabilize pre-existing linkages.
![]()
Inside-out Integrin Signaling: Role of Cytoskeletal Proteins
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES
2 integrins from unstimulated
neutrophils do not engage
2 ligands, and they
co-immunoprecipitate with talin but not
-actinin (16). However, cell
activation by fMet-Leu-Phe induces ligand binding to the
2 integrins and stimulates talin proteolysis and
dissociation from
2 in a manner dependent on the
calcium-dependent protease, calpain. During a later phase of cell activation,
2 now co-precipitates with
-actinin and not talin, an association hypothesized to result from a
change in conformation of the
2 cytoplasmic tail (16).
In this scheme, integrin activation would be initiated by
calpain-dependent release of one integrin-cytoskeleton
linkage and later reinforced by another. This overall model may also
apply to activation of other integrins, but the precise details may
differ. For example, calpain activation in platelets is a relatively
late event, occurring after the initial phase of
IIb
3 activation, and it is responsible
for cleavage of numerous cytoskeletal and signaling proteins, including
the
3 cytoplasmic tail itself (42).
L
2 in phorbol ester-stimulated
Epstein-Barr virus-transformed B lymphocytes exhibits a 10-fold
increase in random diffusion rate, a change that correlates with
increased cell adhesion to ICAM-1 (41). Treatment of these cells with
low concentrations of cytochalasin D, which caps actin filaments
preventing further polymerization, has the same effect, whereas higher
concentrations of cytochalasin D inhibit cell adhesion. Similarly,
exposure of peripheral blood lymphocytes to cytochalasins induces
clustering of
L
2 and adhesion of the
cells to ICAM-1 (43), and the same is observed in peripheral blood-derived T lymphoblasts after cross-linking of the T cell receptor
(44). In leukocytes, it has been proposed that L-plastin, an
actin-bundling protein, may modulate the avidity of
M
2 in a manner dependent on L-plastin
phosphorylation by protein kinase C (45).
IIb
3 in platelets. For example, in
unstimulated platelets a subpopulation of
IIb
3 is associated with the membrane
cytoskeleton, and relatively low concentrations of cytochalasin D or
latrunculin A, which blocks polymerization of actin monomers, induce
ligand binding to
IIb
3 (46). This effect
requires a stimulus, such as ADP released from the washed platelets,
which the authors suggest might increase actin turnover by binding to
purinergic receptors and stimulating the actin filament-severing
activity of gelsolin and the filament-disassembly activity of
ADF-cofilin.
2 and
3
integrin-dependent aggregation of leukocytes and platelets,
respectively (2). However, in adherent platelets inhibition of Rho with
C3 exoenzyme blocks certain postligand binding events, such as the
formation of vinculin patches and actin cables, but it has no effect on agonist-induced activation and ligand binding to
IIb
3 (47). Similarly, C3 exoenzyme blocks
the formation of FA and stress fibers in fibroblasts, but it has no
significant effect on the activation state of
5
1 (48). In these cases, therefore, Rho may function to regulate cell adhesion through effects on
postligand binding events (9).
![]()
Integrin-associated Proteins Regulate Actin Filament Assembly
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES
cytoplasmic tails.
IIb
3, and
phosphorylation of VASP by protein kinase A or protein kinase G
correlates with inhibition of fibrinogen binding to activated platelets
(53). There may be a causal relationship between VASP phosphorylation
and inhibition of
IIb
3 activation because
VASP-deficient murine platelets show enhanced agonist-induced fibrinogen binding to
IIb
3 and the
inhibitory effects of cyclic nucleotides on fibrinogen binding are
reduced (49, 53).
-actinin or talin. This would allow
Mena/VASP to bind to actin filaments via their EVH2 domains or through
profilin that is bound to oligomerized Mena/VASP (Fig. 2).
Microinjection of peptides that inhibit EVH-1 binding to vinculin and
zyxin displace Mena/VASP from FA and cause retraction of membrane
protrusions. Furthermore, a recessive lethal Ena allele contains a
point mutation that impairs zyxin binding in vitro.
Consequently, Mena/VASP function probably requires its targeting to FA
via interactions with
-actinin (54). Surprisingly, mice deficient in
VASP or Mena are viable, fertile, and display relatively mild
phenotypes, which may reflect functional compensation by related family
members (49, 50, 53). Mena-deficient mice that are also heterozygous
for a profilin-1 deletion die perinatally. Thus, a 50% reduction in
profilin-1 sensitizes animals to loss of Mena, consistent with their
cooperation in regulating the actin cytoskeleton (50).
1 and
3 tails
(59), and ankyrin repeats within ILK appear to mediate binding to the
LIM domain-only protein PINCH and recruit it to integrin complexes in
spreading cells (59). PINCH also interacts with Nck-2, an
SH2/SH3-containing protein, and so mediates an association between
Nck-2 and ILK (59). The C-terminal SH3 domain of the closely related
adapter protein Nck-1 binds to WASP (56). This domain is 75% identical to the corresponding Nck-2 SH3 domain, suggesting that a protein complex containing integrin, ILK, PINCH, Nck-2, WASP, and Arp2/3 might
localize actin polymerization to sites of integrin-ECM contact in the
lamellipodia of migrating cells. Some support for this hypothesis comes
from unc-97 mutants in Caenorhabditis elegans. The UNC-97 protein belongs to the PINCH family of LIM domain proteins and is co-localized with
integrin at dense bodies (60), where it is
required for the assembly and stability of these FA-like structures
(60).
integrin cytoplasmic tail to talin is an early and important step and
probably provides a preliminary connection, which is reinforced by
subsequent binding of
-actinin and vinculin. In turn, these proteins
probably function to bring additional F-actin to the adhesion site, and
they may also recruit zyxin, Mena/VASP, and profilin. Recruitment of
WASP and Arp2/3 may lead to further actin polymerization and
reorganization. The large number of actin-binding proteins within
matrix adhesions and their numerous structural and functional
interactions with integrins provide an important basis for the control
of cellular functions by integrins.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
INTRODUCTION
Role of Integrin Cytoplasmic...
Specific Integrin-Cytoskeleton...
Inside-out Integrin Signaling:...
Integrin-associated Proteins...
REFERENCES
1.
Choquet, D.,
Felsenfeld, D. P.,
and Sheetz, M. P.
(1997)
Cell
88,
39-48
2.
Burridge, K.,
and Chrzanowska-Wodnicka, M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
463-518
3.
Liu, S.,
Thomas, S. M.,
Woodside, D. G.,
Rose, D. M.,
Kiosses, W. B.,
Pfaff, M.,
and Ginsberg, M. H.
(1999)
Nature
402,
676-681
4.
Muir, T. W.,
Williams, M. J.,
Ginsberg, M. H.,
and Kent, S. B. H.
(1994)
Biochemistry
33,
7701-7708
5.
Haas, T. A.,
and Plow, E. F.
(1996)
J. Biol. Chem.
271,
6017-6026
6.
Leisner, T. M.,
Wencel-Drake, J. D.,
Wang, W.,
and Lam, S. C.
(1999)
J. Biol. Chem.
274,
12945-12949
7.
Zamir, E.,
Katz, B. Z.,
Aota, S.,
Yamada, K. M.,
Geiger, B.,
and Kam, Z.
(1999)
J. Cell Sci.
112,
1655-1669
8.
Jockusch, B. M.,
Bubeck, P.,
Giehl, K.,
Kroemker, M.,
Moschner, J.,
Rothkegel, M.,
Rudiger, M.,
Schluter, K.,
Stanke, G.,
and Winkler, J.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
379-416
9.
Hall, A.
(1998)
Science
23,
509-514
10.
Reszka, A. A.,
Hayashi, Y.,
and Horwitz, A. F.
(1992)
J. Cell Biol.
117,
1321-1330
11.
Ylanne, J.,
Huuskonen, J.,
O'Toole, T. E.,
Ginsberg, M. H.,
Virtanen, I.,
and Gahmberg, C. G.
(1995)
J. Biol. Chem.
270,
9550-9557
12.
Peter, K.,
and O'Toole, T. E.
(1995)
J. Exp. Med.
181,
315-326
13.
Schultz, J.,
Milpetz, F.,
Bork, P.,
and Ponting, C. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5857-5864
14.
Borowsky, M. L.,
and Hynes, R. O.
(1998)
J. Cell Biol.
143,
429-442
15.
Pfaff, M.,
Liu, S.,
Erle, D. J.,
and Ginsberg, M. H.
(1998)
J. Biol. Chem.
273,
6104-6109
16.
Sampath, R.,
Gallagher, P. J.,
and Pavalko, F. M.
(1998)
J. Biol. Chem.
273,
33588-33594
17.
Calderwood, D. A.,
Zent, R.,
Grant, R.,
Rees, D. J. G.,
Hynes, R. O.,
and Ginsberg, M. H.
(1999)
J. Biol. Chem.
274,
28071-28074
18.
Patil, S.,
Jedsadayanmata, A.,
Wencel-Drake, J. J.,
Wang, W.,
Knezevic, I.,
and Lam, S. C. T.
(1999)
J. Biol. Chem.
274,
28575-28583
19.
Moulder, G. L.,
Huang, M. M.,
Waterston, R. H.,
and Barstead, R. J.
(1996)
Mol. Biol. Cell
7,
1181-1193
20.
Albiges-Rizo, C.,
Frachet, P.,
and Block, M. R.
(1995)
J. Cell Sci.
108,
3317-3329
21.
Priddle, H.,
Hemmings, L.,
Monkley, S.,
Woods, A.,
Patel, B.,
Sutton, D.,
Dunn, G. A.,
Zicha, D.,
and Critchley, D. R.
(1998)
J. Cell Biol.
142,
1121-1133
22.
Kaapa, A.,
Peter, K.,
and Ylanne, J.
(1999)
Exp. Cell Res.
250,
524-534
23.
Tapley, P.,
Horwitz, A.,
Buck, C. A.,
Duggan, K.,
and Rohrschneider, L.
(1989)
Oncogene
4,
325-333
24.
Lewis, J. M.,
and Schwartz, M. A.
(1995)
Mol. Biol. Cell
6,
151-160
25.
Ohta, Y.,
Suzuki, N.,
Nakamura, S.,
Hartwig, J. H.,
and Stossel, T. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2122-2128
26.
Fox, J. W.,
Lamperti, E. D.,
Eksioglu, Y. Z.,
Hong, S. E.,
Feng, Y.,
Graham, D. A.,
Scheffer, I. E.,
Dobyns, W. B.,
Hirsch, B. A.,
Radtke, R. A.,
Berkovic, S. F.,
Huttenlocher, P. R.,
and Walsh, C. A.
(1998)
Neuron
21,
1315-1325
27.
Sharma, C. P.,
Ezzell, R. M.,
and Arnaout, M. A.
(1995)
J. Immunol.
154,
3461-3470
28.
Glogauer, M.,
Arora, P.,
Chou, D.,
Janmey, P. A.,
Downey, G. P.,
and McCulloch, C. A.
(1998)
J. Biol. Chem.
273,
1689-1698
29.
Cunningham, C. C.,
Gorlin, J. B.,
Kwiatkowski, D. J.,
Hartwig, J. H.,
Janmey, P. A.,
Byers, H. R.,
and Stossel, T. P.
(1992)
Science
255,
325-327
30.
Meyer, S. C.,
Sanan, D. A.,
and Fox, J. E.
(1998)
J. Biol. Chem.
273,
3013-3020
31.
Pavalko, F. M.,
Chen, N. X.,
Turner, C. H.,
Burr, D. B.,
Atkinson, S.,
Hsieh, Y. F.,
Qiu, J.,
and Duncan, R. L.
(1998)
Am. J. Physiol.
275,
C1591-C1601
32.
Cattelino, A.,
Albertinazzi, C.,
Bossi, M.,
Critchley, D. R.,
and de Curtis, I.
(1999)
Mol. Biol. Cell
10,
373-391
33.
Law, D. A.,
DeGuzman, F. R.,
Heiser, P.,
Ministri-Madrid, K.,
Killeen, N.,
and Phillips, D. R.
(1999)
Nature
401,
808-811
34.
Jenkins, A. L.,
Nannizzi-Alaimo, L.,
Silver, D.,
Sellers, J. R.,
Ginsberg, M. H.,
Law, D. A.,
and Phillips, D. R.
(1998)
J. Biol. Chem.
273,
13878-13885
35.
Reddy, K. B.,
Gascard, P.,
Price, M. G.,
Negrescu, E. V.,
and Fox, J. E. B.
(1998)
J. Biol. Chem.
273,
35039-35047
36.
Bubeck, P.,
Pistor, S.,
Wehland, J.,
and Jockusch, B. M.
(1997)
J. Cell Sci.
110,
1361-1371
37.
Xu, W.,
Baribault, H.,
and Adamson, E. D.
(1998)
Development
125,
327-337
38.
Hughes, P.,
and Pfaff, M.
(1998)
Trends Cell Biol.
8,
359-364
39.
Hato, T.,
Pampori, N.,
and Shattil, S. J.
(1998)
J. Cell Biol.
141,
1685-1695
40.
Pawson, T.,
and Scott, J. D.
(1997)
Science
278,
2075-2080
41.
Kucik, D. F.,
Dustin, M. L.,
Miller, J. M.,
and Brown, E. J.
(1996)
J. Clin. Invest.
97,
2139-2144
42.
Du, X.,
Saido, T. C.,
Tsubuki, S.,
Indig, F. E.,
Williams, M. J.,
and Ginsberg, M. H.
(1995)
J. Biol. Chem.
270,
26146-26151
43.
Lub, M.,
van Kooyk, Y.,
van Vliet, S. J.,
and Figdor, C. G.
(1997)
Mol. Biol. Cell
8,
341-351
44.
Stewart, M. P.,
McDowall, A.,
and Hogg, N.
(1998)
J. Cell Biol.
140,
699-707
45.
Jones, S. L.,
Wang, J.,
Turck, C. W.,
and Brown, E. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9331-9336
46.
Bennett, J. S.,
Zigmond, S.,
Vilaire, G.,
Cunningham, M. E.,
and Bednar, B.
(1999)
J. Biol. Chem.
274,
25301-25307
47.
Leng, L.,
Kashiwagi, H.,
Ren, X. D.,
and Shattil, S. J.
(1998)
Blood
91,
4206-4215
48.
Zhong, C.,
Chrzanowska-Wodnicka, M.,
Brown, J.,
Shaub, A.,
Belkin, A. M.,
and Burridge, K.
(1998)
J. Cell Biol.
141,
539-551
49.
Aszodi, A.,
Pfeifer, A.,
Ahmad, M.,
Glauner, M.,
Zhou, X. H.,
Ny, L.,
Andersson, K. E.,
Kehrel, B.,
Offermanns, S.,
and Fassler, R.
(1999)
EMBO J.
18,
37-48
50.
Lanier, L. M.,
Gates, M. A.,
Witke, W.,
Menzies, A. S.,
Wehman, A. M.,
Macklis, J. D.,
Kwiatkowski, D.,
Soriano, P.,
and Gertler, F. B.
(1999)
Neuron
22,
313-325
51.
Bachmann, C.,
Fischer, L.,
Walter, U.,
and Reinhard, M.
(1999)
J. Biol. Chem.
274,
23549-23557
52.
Rottner, K.,
Behrendt, B.,
Small, J. V.,
and Weland, J.
(1999)
Nat. Cell Biol.
1,
321-322
53.
Hauser, W.,
Knobeloch, K. P.,
Eigenthaler, M.,
Gambaryan, S.,
Krenn, V.,
Geiger, J.,
Glazova, M.,
Rohde, E.,
Horak, I.,
Walter, U.,
and Zimmer, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8120-8125
54.
Beckerle, M. C.
(1998)
Cell
95,
741-748
55.
Machesky, L. M.,
and Insall, R. H.
(1999)
J. Cell Biol.
146,
267-272
56.
Snapper, S. B.,
and Rosen, F. S.
(1999)
Annu. Rev. Immunol.
17,
905-929
57.
Rohatgi, R.,
Ma, L.,
Miki, H.,
Lopez, M.,
Kirchhausen, T.,
Takenawa, T.,
and Kirschner, M. W.
(1999)
Cell
97,
221-231
58.
Suzuki, T.,
Miki, H.,
Takenawa, T.,
and Sasakawa, C.
(1998)
EMBO J.
17,
2767-2776
59.
Dedhar, S.,
Williams, B.,
and Hannigan, G.
(1999)
Trends Cell Biol.
9,
319-323
60.
Hobert, O.,
Moerman, D. G.,
Clark, K. A.,
Beckerle, M. C.,
and Ruvkun, G.
(1999)
J. Cell Biol.
144,
45-57
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Mertins, H. C. Eberl, J. Renkawitz, J. V. Olsen, M. L. Tremblay, M. Mann, A. Ullrich, and H. Daub Investigation of Protein-tyrosine Phosphatase 1B Function by Quantitative Proteomics Mol. Cell. Proteomics, September 1, 2008; 7(9): 1763 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hirata, H. Tatsumi, and M. Sokabe Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner J. Cell Sci., September 1, 2008; 121(17): 2795 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Auger and S. P. Watson Dynamic Tyrosine Kinase-Regulated Signaling and Actin Polymerisation Mediate Aggregate Stability Under Shear Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1499 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thom, V. M. Bhopale, D. J. Mancini, and T. N. Milovanova Actin S-Nitrosylation Inhibits Neutrophil {beta}2 Integrin Function J. Biol. Chem., April 18, 2008; 283(16): 10822 - 10834. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yu, L. Erb, R. Shivaji, G. A. Weisman, and C. I. Seye Binding of the P2Y2 Nucleotide Receptor to Filamin A Regulates Migration of Vascular Smooth Muscle Cells Circ. Res., March 14, 2008; 102(5): 581 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang and S. J. Gunst Interactions of Airway Smooth Muscle Cells with Their Tissue Matrix: Implications for Contraction Proceedings of the ATS, January 1, 2008; 5(1): 32 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, Y. Wu, C. Wu, and S. J. Gunst Integrin-linked Kinase Regulates N-WASp-mediated Actin Polymerization and Tension Development in Tracheal Smooth Muscle J. Biol. Chem., November 23, 2007; 282(47): 34568 - 34580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vielreicher, G. Harms, E. Butt, U. Walter, and A. Obergfell Dynamic Interaction between Src and C-terminal Src Kinase in Integrin {alpha}IIbbeta3-mediated Signaling to the Cytoskeleton J. Biol. Chem., November 16, 2007; 282(46): 33623 - 33631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, C. V. Carman, M. Kim, M. Shimaoka, T. A. Springer, and B.-H. Luo Requirement of {alpha} and {beta} subunit transmembrane helix separation for integrin outside-in signaling Blood, October 1, 2007; 110(7): 2475 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, Y.-Q. Ma, Y. Tu, K. Chen, S. Wu, K. Fukuda, J. Qin, E. F. Plow, and C. Wu The MIG-2/Integrin Interaction Strengthens Cell-Matrix Adhesion and Modulates Cell Motility J. Biol. Chem., July 13, 2007; 282(28): 20455 - 20466. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bix, R. A. Iozzo, B. Woodall, M. Burrows, A. McQuillan, S. Campbell, G. B. Fields, and R. V. Iozzo Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the {alpha}2{beta}1-integrin receptor Blood, May 1, 2007; 109(9): 3745 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. LaGier, S. H. Yoo, E. C. Alfonso, S. Meiners, and M. E. Fini Inhibition of Human Corneal Epithelial Production of Fibrotic Mediator TGF-{beta}2 by Basement Membrane-Like Extracellular Matrix Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1061 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Van de Walle, A. Schoolmeester, B. F. Iserbyt, J. M. E. M. Cosemans, J. W. M. Heemskerk, M. F. Hoylaerts, A. Nurden, K. Vanhoorelbeke, and H. Deckmyn Activation of {alpha}IIb{beta}3 is a sufficient but also an imperative prerequisite for activation of {alpha}2{beta}1 on platelets Blood, January 15, 2007; 109(2): 595 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, Z. Li, Z. Feng, J. Wang, C. Ouyang, W. Liu, B. Fu, G. Cai, C. Wu, R. Wei, et al. Integrin-Linked Kinase Induces Both Senescence-Associated Alterations and Extracellular Fibronectin Assembly in Aging Cardiac Fibroblasts J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1232 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Hantgan, M. C. Stahle, J. H. Connor, D. A. Horita, M. Rocco, M. A. McLane, S. Yakovlev, and L. Medved Integrin {alpha}IIbbeta3:ligand interactions are linked to binding-site remodeling. Protein Sci., August 1, 2006; 15(8): 1893 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pan, J. Xie, F. Ye, and S.-J. Gao Modulation of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by MEK/ERK, JNK, and p38 Multiple Mitogen-Activated Protein Kinase Pathways during Primary Infection. J. Virol., June 1, 2006; 80(11): 5371 - 5382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Filla, A. Woods, P. L. Kaufman, and D. M. Peters {beta}1 and {beta}3 Integrins Cooperate to Induce Syndecan-4-Containing Cross-linked Actin Networks in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1956 - 1967. [Abstract] [F |